🧠AI AnalysisCombination Strategy Overcomes Drug Resistance in Preclinical Breast Cancer Models
Researchers at UT MD Anderson used a computational platform to uncover a dual-drug approach that suppressed tumor growth in treatment-resistant breast cancer models.